In 2019, Yoon et al. investigated the use of PDT with verteporfin and anti-VEGF (bevacizumab) in eight eyes of SJS/TEN patients who had corneal neovascularization refractory to topical corticosteroids [128]. This evidence concerns the gene VEGFA and Schwartz-Jampel syndrome.